Journal article
Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes
Stem cells international, Vol.2017, pp.1-10
2017
DOI: 10.1155/2017/5153625
PMCID: PMC5380852
PMID: 28421116
Abstract
Human pluripotent stem cells derived cardiomyocytes (PSC-CMs) have been widely used for disease modeling, drug safety screening, and preclinical cell therapy to regenerate myocardium. Most studies have utilized PSC-CM grown in vitro for a relatively short period after differentiation. These PSC-CMs demonstrated structural, electrophysiological, and mechanical features of primitive cardiomyocytes. A few studies have extended in vitro PSC-CM culture time and reported improved maturation of structural and electromechanical properties. The degree of mitochondrial maturation, however, remains unclear. This study characterized the development of mitochondria during prolonged in vitro culture. PSC-CM demonstrated an improved mitochondrial maturation with prolonged culture, in terms of increased mitochondrial relative abundance, enhanced membrane potential, and increased activity of several mitochondrial respiratory complexes. These are in parallel with the maturation of other cellular components. However, the maturation of mitochondria in PSC-CMs grown for extended in vitro culture exhibits suboptimal maturation when compared with the maturation of mitochondria observed in the human fetal heart during similar time interval.
Details
- Title: Subtitle
- Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes
- Creators
- Dao-Fu Dai - Mitochondria and Metabolism Center, Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA, USA, Department of Pathology, University of Washington, Seattle, WA, USAMaria Elena Danoviz - Mitochondria and Metabolism Center, Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA, USABrian Wiczer - Mitochondria and Metabolism Center, Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA, USAMichael A Laflamme - Department of Pathology, University of Washington, Seattle, WA, USA, Toronto General Research Institute, McEwen Centre for Regenerative Medicine, University Health Network, Toronto, ON, CanadaRong Tian - Mitochondria and Metabolism Center, Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA, USA, Department of Pathology, University of Washington, Seattle, WA, USA
- Resource Type
- Journal article
- Publication Details
- Stem cells international, Vol.2017, pp.1-10
- DOI
- 10.1155/2017/5153625
- PMID
- 28421116
- PMCID
- PMC5380852
- NLM abbreviation
- Stem Cells Int
- ISSN
- 1687-966X
- eISSN
- 1687-9678
- Language
- English
- Date published
- 2017
- Academic Unit
- Pathology; Iowa Neuroscience Institute; Radiation Oncology
- Record Identifier
- 9984046832502771
Metrics
21 Record Views